Metabolic activation and detoxification of arylamines

Current Medicinal Chemistry

Volumn 3, Issue 3, 1996, Pages 195-210

  Hanna, Patrick E ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; AROMATIC AMINE; CYTOCHROME P450; DAPSONE; PROCAINAMIDE; SULFENAMIDE DERIVATIVE;

DRUG DETOXIFICATION; HUMAN; METABOLIC ACTIVATION; NONHUMAN; REVIEW;

EID: 0030004042     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (164)

1. Rehn, L. Blasengeschuwülste bei Fuchsin-Arbeitem. Arch. Klin. Chir. 1895, 50, 588-600.
2. Garner, R.C.; Martin, C.N.; Clayson, D.B. Carcinogenic Aromatic Amines and Related Compounds. In Chemical Carcinogens, Second Edition; C.E. Searle, Ed.; American Chemical Society: Washington, D.C., 1984; Vol. 1, pp 175-276.
3. Lotlikar, P.B. Nitrogenous Carcinogenic Industrial Chemicals. In Carcinogens in Industry and the Environment, J.M. Sontag, Ed.; Marcel Dekker: New York, 1981; pp 345-437.
4. Sugimura, T. History, Present and Future of Heterocyclic Amines, Cooked Food Mutagens. In Heterocyclic Amines in Cooked Foods: Possible Human Carcinogens; R.H. Adamson, J.A. Gustafsson, N. Ito, M. Nagao, T. Sugimura, K. Wakabayashi, Y. Yamazoe, Eds.; Princeton Scientific: Princeton, N.J., 1995; pp 214-231.
5. Layton, D.W.; Bogen, K.T.; Knize, M.G.; Hatch, F.T.; Johnson, V.M.; Felton, J.S. Cancer Risk of Heterocyclic Amines in Cooked Foods: an Analysis and Implications for Research. Carcinogenesis 1995, 16, 39-52.
6. Eisenbrand, G.; Tang, W. Food-borne Heterocyclic Amines. Chemistry, Formation, Occurrence and Biological Activities. A Literature Review. Toxicol. 1993, 84, 1-82.
7. Mandell, G.L.; Sande, M.A. Antimicrobial Agents. In The Pharmacological Basis of Therapeutics; A.G. Gilman, T.W. Rall, A.S. Nies, P. Taylor, Eds.; Pergamon Press: New York, 8th Edition, 1990; pp 1047-1057.
8. Weisburger, J.H.; Weisburger, E.K. Biochemical Formation and Pharmacological, Toxicological, and Pathological Properties of Hydroxylamines and Hydroxamic Acids. Pharmacol. Rev. 1973, 25, 1-66.
9. Butler, M.A.; Iwasaki, M.; Guengerich, F.P.; Kadlubar, F.F. Human Cytochrome P-450PA (P-450IA2), the Phenacetin O-Deethylase, Is Primarily Responsible for the Hepatic 3-Demethylation of Caffeine and N-Oxidation of Carcinogenic Arylamines. Proc. Natl. Acad. Sci. USA, 1989, 86, 7696-7700.
10. Doerge, D.R.; Corbett, M.D. Primary Arylamine Oxidation by a Flavinhydroperoxide: a Study of the Basis for the Substrate Specificity of the Flavoprotein Monooxygenase. Biochem. Pharmacol. 1984, 33, 3615-3619.
11. Hammons, G.J.; Guengerich, F.P.; Weis, C.C.; Beland, F.A.; Kadlubar, F.F. Metabolic Oxidation of Carcinogenic Arylamines by Rat, Dog and Human Hepatic Microsomes and P-450 Monooxygenases. Cancer Res. 1985, 45, 3578-3585.
12. Malejka-Giganti, D.; Ritter, C.L. Peroxidative Metabolism of Carcinogenic N-Arylhydroxamic Acids: Implications for Tumorigenesis. Environ. Health Perspect. 1994, 102 (S6), 75-81.
13. Poulsen, L.L.; Masters, B.S.S.; Ziegler, D.M. Mechanism of 2-Naphthylamine Oxidation Catalyzed by Pig Liver Microsomes. Xenobiotica 1976, 6, 481-498.
14. Kiese, M. The Biochemical Production of Ferrihemoglobin-Forming Derivatives from Aromatic Amines and Mechanisms of Ferrihemoglobin Formation. Pharmacol. Rev. 1966, 18, 1091-1161.
15. Nelson, S.D. Arylamines and Arylamides: Oxidation Mechanisms. In Bioactivation of Foreign Compounds; M.W. Anders, Ed.; Academic Press, San Diego, CA, 1985, pp 349-374.
16. Eyer, P. Detoxication of N-Oxygenated Arylamines in Erythrocytes. An Overview. Xenobiotica 1988, 18, 1327-1333.
17. Becker, A.R.; Sternson, L.A. Nonenzymatic Reduction of Nitrosobenzene to Phenylhydroxylamine by NAD(P)H. Bioorg. Chem. 1980, 9, 305-312.
18. Corbett, M.D.; Wei, C.; Corbett, B.R. Nitroreductase-Dependent Mutagenicity of p-Nitrophenylhydroxylamine and its N-Acetyl and N-Formyl Hydroxamic Acids. Carcinogenesis 1985, 6, 727-732.
19. Maskos, Z.; Winston, G.W. Alcohol Dehydrogenase-Dependent Reduction of 2-Nitrosofluorene and Rearrangement of N-Hydroxy-2-aminofluorene. Biochem. 1993, 32, 12768-12773.
20. Lotlikar, P.D.; Miller, E.G.; Miller, J.A.; Margreth, A. The Enzymatic Reduction of the N-Hydroxy Derivatives of 2-Acetylaminofluorene and Related Carcinogens by Tissue Preparations. Cancer Res. 1965, 25, 1743-1752.
21. Booth, J.; Boyland, E. The Biochemistry of Aromatic Amines. Biochem. J. 1964, 91, 362-369.
22. Kadlubar, F.F.; McKee, E.M.; Ziegler, D.M. Reduced Pyridine Nucleotide-Dependent N-Hydroxy Amine Oxidase and Reductase Activities of Hepatic Microsomes. Arch. Biochem. Biophys. 1973, 156, 46-57.
23. Clement, B.; Kunze, T. The Reduction of 6-N-Hydroxylaminopurine to Adenine by Xanthine Oxidase. Biochem. Pharmacol. 1992, 44, 1501-1509.
24. Williams, J.R., Jr.; Grantham, P.H.; Marsh, H.H., III, Weisburger, J.H.; Weisburger, E.K. Participation of Liver Fractions and of Intestinal Bacteria in the Metabolism of N-Hydroxy-2-fluorenylacetamide in the Rat. Biochem. Pharmacol. 1970, 19, 173-188.
25. Yamazoe, Y.; Ishii, K.; Yamaguchi, N.; Kamataki, T.; Kato, R. Reduction of N-Hydroxy-2-acetylaminofluorene by Liver Microsomes. Biochem. Pharmacol. 1980, 29, 2183-2188.
26. Kitamura, S.; Tatsumi, K. Purification of N-Hydroxy-2-acetylaminofluorene Reductase from Rabbit Liver Cytosol. Biochem. Biophys. Res. Comm. 1985, 133, 67-74.
27. Kitamura, S.; Sugihara, K.; Tatsumi, K. Reductase Activity of Aldehyde Oxidase Toward the Carcinogen N-Hydroxy-2-Acetylaminofluorene and the Related Hydroxamic Acids. Biochem. Biophys. Res. Comm. 1994, 34, 1197-1203.
28. 4-Acetylsulfadiazine Crystalluria in a Patient with the Acquired Immune Deficiency Syndrome (AIDS). Clin. Chim. Acta 1994, 230, 221-224.
29. Weber, W.W. The Acetylator Genes and Drug Response, Oxford University Press: Oxford and New York, 1987.
30. Grant, D.M. Molecular Genetics of the N-Acetyltransferases. Pharmacogenetics 1993, 3, 45-50.
31. Kato, R.; Yamazoe, Y. Metabolic Activation of N-Hydroxylated Metabolites of Carcinogenic and Mutagenic Arylamines and Arylamides by Esterification. Drug Metab. Rev. 1994, 26, 413-430.
32. Hein, D.W. Acetylator Genotype and Arylamine-Induced Carcinogenesie. Biochim. Biophys. Acta 1988, 948, 37-66.
33. Hanna, P.E. N-Acetyltransferases, O-Acetyltransfereses and N,O-Acetyltransferases: Enzymology and Bioactivation. Adv. Pharmacol. 1994, 27, 401-429.
34. Rickert, D.E. Metabolism of Nitroaromatic Compounds. Drug Metab. Rev. 1987, 18, 23-53.
35. Hewick, D.S. Reductive Metabolism of Nitrogen-Containing Functional Groups. In Metabolic Basis of Detoxication; W.B. Jakoby, J.R. Bend, J. Caldwell, Eds.; Academic Press: San Diego, CA, 1982, pp 151-170.
36. Chae, Y.-H.; Yun, C.-H.; Guengerich, F.P.; Kadlubar, F.F.; El-Bayoumy, K. Roles of Human Hepatic and Pulmonary Cytochrome P-450 Enzymes in the Metabolism of the Environmental Carcinogen 6-Nitrochrysene. Cancer Res. 1993, 53, 2028-2034.
37. Bauer, S.L.; Howard, P.C. Kinetics and Cofactor Requirements for the Nitroreductive Metabolism of 1-Nitropyrene and 3-Nitrofluoranthene by Rabbit Liver Aldehyde Oxidase. Carcinogenesis 1991, 12, 1545-1549.
38. Rieder, M.J.; Uetrecht, J.; Shear, N.H.; Cannon, M.; Miller, M.; Spielberg, S.P. Diagnosis of Sulfonamide Hypersensitivity Reactions by In-Vitro "Rechallenge" with Hydroxylamine Metabolites. Ann. Int. Med. 1989, 110, 286-289.
39. Leeder, J.S.; Dosch, H.-M.; Spielberg, S.P. Cellular Toxicity of Sulfamethoxazole Metabolites. I. Inhibition of Intracellular Esterase Activity Prior to Cell Death. Biochem. Pharmacol. 1991, 47, 567-574.
40. Leeder, J.S.; Nakhooda, A.; Spielberg, S.P.; Dorsch, H.-M. Cellular Toxicity of Sulfamethoxazole Reactive Metabolites. II. Inhibition of Natural Killer Activity in Human Peripheral Blood Mononuclear Cells. Biochem. Pharmacol. 1991, 41, 575-583.
41. Rieder, M.J.; Uetrecht, J.; Shear, N.H.; Spielberg, S.P. Synthesis and In Vitro Toxicity of Hydroxylamine Metabolites of Sulfonamides. J. Pharmacol. Exp. Ther. 1988, 244, 724-728.
42. Cribb, A.; Spielberg, S.P. Sulfamethoxazole is Metabolized to the Hydroxylamine in Humans. Clin. Pharmacol. Ther. 1992, 51, 522-526.
43. 4-Hydroxylation of Sulfamethoxazole by Cytochrome P-450 of the Cytochrome P4502C Subfamily and Reduction of Sulfamethoxazole Hydroxylamine in Human and Rat Hepatic Microsomes. Drug Metab. Dispos. 1995, 23, 406-414.
44. Cribb, A.E.; Miller, M.; Tesoro, A.; Spielberg, S.P. Peroxidase-Dependent Oxidation of Sulfonamides by Monocytes and Neutrophils from Humans and Dogs. Mol. Pharmacol. 1990, 38, 744-751.
45. Shear, N.H.; Spielberg, S.P. In Vitro Evaluation of a Toxic Metabolite of Sulfadiazine. Can. J. Physiol. Pharmacol. 1985, 63, 1370-1372.
46. Carr, A.; Tindall, B.; Penny, R.; Cooper, D.A. In vitro Cytotoxicity as a Marker of Hypersensitivity to Sulfamethoxazole in Patients with HIV. Clin. Exp. Immunol. 1993, 94, 21-25.
47. Cribb, A.; Miller, M.; Leeder, J.S.; Hill, J.; Spielberg, S.P. Reactions of Nitroso and Hydroxylamine Metabolites of Sulfamethoxazole with Reduced Glutathione. Drug Metab. Dispos. 1991, 19, 900-906.
48. Kazanis, S.; McClelland, R. Electrophilic Intermediate in the Reaction of Glutathione and Nitrosoarenes. J. Am. Chem. Soc. 1992, 114, 3052-3059.
49. Hein, D.W.; Ferguson, R.J., Doll, M.A.; Rustan, T.D.; Gray, K. Molecular Genetics of Human Polymorphic N-Acetyltransferase: Enzymatic Analysis of 15 Recombinant Wild-Type, Mutant and Chimeric NAT2 Allozymes. Human Mol. Genetics 1994, 3, 729-734.
50. Weber, W.W.; Vatsis, K.P. Individual Variability in p-Aminobenzoic Acid N-Acetylation by Human N-Acetyltransferase (NAT1) of Peripheral Blood. Phamacogenetics 1993, 3, 209-212.
51. Rieder, M.J.; Shear, N.H.; Kanee, A.; Tang, B.K.; Spielberg, S.P. Prominence of Slow Acetylator Phenotype Among Patients with Sulfonamide Hypersensitivity Reactions. Clin. Pharmacol. Ther. 1991, 49, 13-17.
52. Cribb, A.E.; Nakamura, H.; Grant, D.M.; Miller, M.A.; Spielberg, S.P. Role of Polymorphic and Monomorphic Human Arylamine N-Acetyltransferases in Determining Sulfamethoxazole Metabolism. Biochem. Pharmacol. 1993, 45, 1277-1282.
53. Lee, B.L.; Wong, D.; Sullam, P.M. Altered Patterns of Drug Metabolism in Patients with Acquired Immunodeficiency Syndrome. Clin. Pharmacol. Ther. 1993, 53, 529-535.
54. Carr, A.; Gross, A.S.; Hoskins, J.M.; Penny, R.; Cooper, D.A. Acetylation Phenotype and Cutaneous Hypersensitivity to Trimethoprim-Sulfamethoxazole in HIV-Infected Patients. AIDS, 1994, 333-337.
55. Delomenie, C.; Grant, D.M.; Mathelier-Fusade, P.; Leynadier, F.; Jacqz-Algrain, E.; Rozenbaum, W.; Krishnamoorthy, R.; Dupret, J.-M. N-Acetylation Genotype and Risk of Severe Reactions to Sulphonamides in AIDS Patients. Br. J. Clin. Pharmacol. 1994, 38, 581-582.
56. Jollow, D.J.; Bradshaw, T.P.; McMillan, D.C. Dapsone-Induced Hemolytic Anemia. Drug Metab. Rev. 27, 1995, 107-124.
57. Coleman, M.D.; Tingle, M.D. Use of a Metabolic Inhibitor to Reduce Dapsone-Dependent Haematological Toxicity. Drug Dev. Res. 1992, 25, 1-16.
58. Gelber, R.; Peters, J.H.; Gordon, G.R.; Glazko, A.J.; Levy, L. The Polymorphic Acetylation of Dapsone in Man. Clin. Pharmacol. Ther. 1971, 12, 225-238.
59. Philip, P.A.; Roberts, M.S.; Rogers, H.J. A Rapid Method for Determination of Acetylation Phenotype Using Dapsone. Br. J. Clin. Pharmacol. 1984, 17, 465-469.
60. Palemanda, J.R.; Hickman, D.; Ward, A.; Sim, E.; Romkes-Sparks, M.; Unadkat, J.D. Dapsone Acetylation by Human Liver Arylamine N-Acetyltransferases and Interaction with Antiopportunistic Infection Drugs. Drug Metab. Dispos. 1995, 23, 473-477.
61. Israili, Z.H.; Cucinell, S.A.; Vaught, J.; Davis, E.; Lesser, J.M.; Dayton, P.G. Studies of the Metabolism of Dapsone in Man and Experimental Animals: Formation of N-Hydroxy Metabolites. J. Pharmacol. Exp. Ther. 1973, 187, 138-151.
62. May, D.G.; Porter, J.A.; Uetrecht, J.P.; Wilkinson, G.R.; Branch, R.A. The Contribution of N-Hydroxylation to Dapsone Pharmacokinetics in Normal Subjects. Clin. Pharmacol. Ther. 1990, 48, 619-627.
63. Fleming, C.M.; Branch, R.A.; Wilkinson, G.R.; Guengerich, F.P. Human Liver Microsomal N-Hydroxylation of Dapsone by Cytochrome P-4503A4. Mol. Pharmacol. 1992, 41, 975-980.
64. Coleman, M.D.; Rhodes, L.E.; Scott, A.K.; Verbov, J.L.; Friedmann, P.S.; Breckenridge, A.M.; Park, B.K. The Use of Cimetidine to Reduce Dapsone-Dependent Methaemoglobinemia in Dermatitis Herpetiformis Patients. Br. J. Clin. Pharmacol. 1992, 34, 244-249.
65. Uetrecht, J.; Nasir, Z.; Shear, N.H.; Biggar, W.D. Metabolism of Dapsone to a Hydroxylamine by Human Neutrophils and Mononuclear Cells. J. Pharmacol. Exp. Ther. 1988, 245, 274-279.
66. Uetrecht, J.P. The Role of Leukocyte-Generated Reactive Metabolites in the Pathogenesis of Idiosyncratic Drug Reactions. Drug Metab. Rev. 1992, 24, 299-366.
67. Glader, B.E.; Conrad, M.E. Hemolysis by Diphenylsulfones: Comparative Effects of DDS and Hydroxylamine DDS. J. Lab. Clin. Med. 1973, 81, 267-272.
68. Scott, G.L.; Rasbridge, M.R. The in Vitro Action of Dapsone and Its Derivatives on Normal and G6PD-Deficient Red Cells. Br. J. Haemotol. 1973, 24, 307-317.
69. Degowin, R.L.; Eppes, R.B.; Powell, R.D.; Carson, P.E. The Haemolytic Effects of Diphenylsulfone (DDS) in Normal Subjects and in Those with Glucose-6-Phosphate Dehydrogenase Deficiency. Bull. WHO 1966, 35, 165-179.
70. Grossman, S.; Budinsky, R.; Jollow, D. Dapsone-Induced Hemolytic Anemia: Role of Glucose-6-Phosphate Dehydrogenase in the Hemolytic Response of Rat Erythrocytes to N-Hydroxydapsone. J. Pharmacol. Exp. Ther. 1995, 273, 870-877.
71. Grossman, S.J.; Jollow, D.J. Role of Dapsone Hydroxylamine in Dapsone-Induced Hemolytic Anemia. J. Pharmacol. Exp. Ther. 1988, 244, 118-125.
72. McMillan, D.C.; Simson, J.V.; Budinsky, R.A.; Jollow, D.J. Dapsone-Induced Hemolytic Anemia: Effect of Dapsone Hydroxylamine on Sulfhydryl Status, Membrane Skeletal Proteins and Morphology of Human and Rat Erythrocytes. J. Pharmacol. Exp. Ther. 1995, 274, 540-547.
73. Bigger, J.T. Jr.; Hoffman, B.F. Antiarrythmic Drugs. In The Pharmacological Basis of Therapeutics; A.G. Gilman, T.W. Rall, A.S. Nies, P. Taylor, Eds.; Pergamon Press: New York, 8th edition, 1990; pp 840-873.
74. Freeman, R.W.; Uetrecht, J.P.; Woosley, R.L.; Oates, J.A.; Harbison, R.D. Covalent Binding of Procainamide In Vitro and In Vivo to Hepatic Protein in Mice. Drug Metab. Dispos. 1981, 9, 188-192.
75. Uetrecht, J.P.; Sweetman, B,J.; Woosley, R.L.; Oates, J.A. Metabolism of Procainamide to a Hydroxylamine by Rat and Human Hepatic Microsomes. Drug Metab. Dispos. 1984, 12, 77-81.
76. Uetrecht, J.P. Reactivity and Possible Significance of Hydroxylamine and Nitroso Metabolites of Procainamide. J. Pharmacol. Exp. Ther. 1985, 232, 420-425.
77. Uetrecht, J.; Zahid, N.; Rubin, R. Metabolism of Procainamide to a Hydroxylamine by Human Neutrophils and Mononuclear Leukocytes. Chem. Res. Toxicol. 1988, 1, 74-78.
78. Rubin, R.L.; Curnutte, J.T. Metabolism of Procainamide to the Cytotoxic Hydroxylamine by Neutrophils Activated In Vitro. J. Clin. Invest. 1989, 83, 1336-1343.
79. Uetrecht, J.; Sokoluk, B. Comparative Metabolism and Covalent Binding of Procainamide by Human Leukocytes. Drug Metab. Dispos. 1992, 20, 120-123.
80. Uetrecht, J.P.; Zahid, N. N-Chlorination and Oxidation of Procainamide by Myeloperoxidase: Toxicological Implications. Chem. Res. Toxicol. 1991, 4, 218-222.
81. Wheeler, J.F.; Adams, L.E.; Mongey, A.-B.; Roberts, S.M.; Heineman, W.R.; Hess, E.V. Determination of Metabolically Derived Nitroprocainamide in the Urine of Procainamide-Dosed Humans and Rats by Liquid Chromatography with Electrochemical Detection. Drug Metab. Dispos. 1991, 19, 691-693.
82. Vineis, P. Epidemiology of Cancer from Exposure to Arylamines. Environ. Health Persp. 1994, 102 (Suppl. 6), 7-10.
83. Vineis, P. Epidemiological Models of Carcinogenesis: The Example of Bladder Cancer. Cancer Epidemiol. Biomarkers Prev. 1992, 1, 149-153.
84. Stavric, B. Biological Significance of Trace Levels of Mutagenic Heterocyclic Aromatic Amines in the Human Diet: A Critical Review. Food Chem. Toxicol. 1994, 32, 977-994.
85. Adamson, R.H.; Thorgeirsson, U.P.; Snyderwine, E.G.; Thorgeirsson, S.S.; Reeves, J.; Dalgard, D.W.; Takayama, S.; Sugimura, T. Carcinogenicity of 2-Amino-3-methylimidazo[4,5-f]quinoline in Nonhuman Primates: Induction of Tumors in Three Macaques. Jpn. J. Cancer Res., 1990, 81, 10-14.
86. Tamano, S.; Hasegawa, R.; Hagiwara, A.; Sugimura, T.; Ito, N. Carcinogenicity of a Mutagenic Compound from Food, 2-Amino-3-methyl-9H-pyrido[2,3-b]indole (MeAαC) in Male F344 Rats. Carcinogenesis 1994, 15, 2009-2015.
87. 1 Male Mouse. Cancer Lett. 1992, 62, 205-209.
88. Ghoshal, A.; Preiseggar, K.-H.; Takayama, S.; Thorgeirsson, S.S.; Snyderwine, E.G. Induction of Mammary Tumors in Female Sprague-Dawley Rats by the Food Derived Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and Effect of Dietary Fat. Carcinogenesis 1994, 15, 2429-2433.
89. Ito, N.; Hasegawa, R.; Sano, M.; Tamano, S.; Esumi, H.; Takayama, S.; Sugimura, T. A New Colon and Mammary Carcinogen in Cooked Food, 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhlP). Carcinogenesis 1991, 12, 1503-1506.
90. Sinha, R.; Rothman, N.; Brown, E.D.; Salmon, C.P.; Knize, M.G.; Swanson, C.A.; Rossi, S.C.; Mark, S.D.; Levander, O.A.; Felton, J.S. High Concentrations of the Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhlP) Occur in Chicken but Are Dependent on the Cooking Method. Cancer Res. 1995, 55, 4516-4519.
91. Manabe, S.; Tohyama, K.; Wada, O.; Aramaki, T. Detection of a Carcinogen, 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhlP), in Cigarette Smoke Condensate. Carcinogenesis 1991, 12, 1945-1947.
92. Manabe, S.; Suzuki, H.; Wada, O.; Ueki, A. Detection of the Carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhlP) in Beer and Wine. Carcinogenesis 1993, 14, 899-901.
93. Nagao, M.; Ushijima, T.; Wakabayashi, K.; Ochiai, M.; Kushida, H.; Sugimura, T.; Hasegawa, R.; Shirai, T.; Ito, N. Dietary Carcinogens and Mammary Carcinogenesis. Induction of Rat Mammary Carcinomas by Administration of Heterocyclic Amines in Cooked Foods. Cancer 1994, 74 (Suppl.), 1063-1069.
94. Snyderwine, E.G. Some Perspectives on the Nutritional Aspects of Breast Cancer Research. Food-Derived Heterocyclic Amines as Etiologic Agents in Human Mammary Cancer. Cancer 1994, 74 (Suppl.), 1070-1077.
95. Nagao, M.; Sugimura, T. Carcinogenic Factors in Food with Relevance to Colon Cancer Development. Mut. Res. 1993, 290, 43-51.
96. Miller, J.A. Research in Chemical Carcinogenesis with Elizabeth Miller. A Trail of Discovery with Our Associates. Drug Meteb. Rev. 1994, 26, 1-36.
97. Miller, E.G.; Miller, J.A. Searches for Ultimate Chemical Carcinogens and Their Reactions with Cellular Macromolecules. Cancer 1981, 47, 2327-2345.
98. Beland, F.A.; Kadlubar, F.F. Metabolic Activation and DNA Adducts of Aromatic Amines and Nitroaromatic Hydrocarbons. Handbook Exptl. Pharmacol. 1990, 94/1, 267-325.
99. McManus, M.E.; Felton, J.S.; Knize, M.G.; Burgess, W.M.; Roberts-Thompson, S.; Pond, S.M.; Stupans, I.; Veronese, M.E. Activation of the Food-Derived Mutagen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by Rabbit and Human Liver Microsomes and Purified Forms of Cytochrome P-450. Carcinogenesis 1989, 10, 357-363.
100. Boobis, A.R.; Lynch, A.M.; Murray, S.; de la Torre, R.; Solans, A; Farré, M.; Segura, J.; Gooderham, N.J.; Davies, D.S. CYP1A2-Catalyzed Conversion of Dietary Heterocyclic Amines to Their Proximate Carciongens is Their Major Route of Metabolism in Humans. Cancer Res. 1994, 54, 89-94.
101. Zhao, K.; Murray, S.; Davies, D.S.; Boobis, A.R.; Gooderham, N.J. Metabolism of the Food Derived Mutagen and Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhlP) by Human Liver Microsomes. Carcinogenesis 1994, 15, 1285-1288.
102. Turesky, R.J.; Lang, N.P.; Butler, M.A.; Teitel, C.H.; Kadlubar, F.F. Metabolic Activation of Carcinogenic Heterocyclic Aromatic Amines by Human Liver and Colon. Carcinogenesis 1991, 12, 1839-1845.
103. Lin, D.; Kadlerlik, K.R.; Turesky, R.J.; Miller, D.W.; Lay, J.O. Jr.; Kadlubar, F.F. Identification of N-(Deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine as the Major Adduct Formed by the Food-Borne Carcinogen, 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, with DNA. Chem. Res. Toxicol. 1992, 5, 691-697.
104. Snyderwine, E.G.; Roller, P.P.; Adamson, R.H.; Sato, S.; Thorgeirsson, S.S. Reaction of N-Hydroxylamine and N-Acetoxy Derivatives of 2-Amino-3-methylimidazo[4,5-f]quinoline with DNA. Synthesis and Identification of N-(deoxyguanosin-8-yl)-IQ. Carcinogenesis 1988, 9, 1061-1965.
105. Hanna, P.E.; Banks, R.B. Arylhydroxylamines and Arylhydroxamic Acids: Conjugation Reactions. In Bioactivation of Foreign Compounds; M.W. Anders, Ed.; Academic Press: Orlando, FL, 1985; pp 401-430.
106. Lin, D.-X.; Lang, N.P.; Kadlubar, F.F. Species Differences in the Biotransformation of the Food-Borne Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by Hepatic Microsomes and Cytosols from Humans, Rats, and Mice. Drug Metab. Dispos. 1995, 23, 518-524.
107. Ozawa, S.; Chow, H.-C.; Kadlubar, F.F.; Nagata, K.; Yamazoe, Y.; Kato, R. Activation of 2-Hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine by cDNA-Expressed Human and Rat Arylsulfotransferases. Jpn. J. Cancer Res. 1994, 85, 1220-1228.
108. Chou, H.-C.; Lang, N.P.; Kadlubar, F.F. Metabolic Activation of N-Hydroxyarylamines and N-Hydroxy Heterocyclic Amines by Human Sulfotransferase(s). Cancer Res. 1995, 55, 525-529.
109. van de Poll, M.L.M.; Venizelos, V.; Meerman, J.H.N. Sulfation-Dependent Formation of N-Acetylated and Deacetylated DNA Adducts of N-Hydroxy-4-acetylaminobiphenyl in Male Rat Liver in vivo and in Isolated Hepatocytes. Carcinogenesis 1990, 11, 1775-1781.
110. Risch, A.; Wallace, D.M.A.; Bathers, S.; Sim, E. Slow N-Acetylation Genotype Is a Susceptibility Factor in Occupational and Smoking Related Bladder Cancer. Human Mol. Genetics 1995, 4, 231-236.
111. Yu, M.C.; Skipper, P.L.; Taghizadeh, K.; Tannenbaum, S.R.; Chan, K.K.; Henderson, B.E.; Ross, R.K. Acetylator Phenotype, Aminobiphenyl-Hemoglobin Adduct Levels, and Bladder Cancer Risk in White, Black, and Asian Men in Los Angeles, California. J. Natl. Cancer Inst. 1994, 86, 712-716.
112. Vineis, P.; Caporaso, N.; Tannenbaum, S.R.; Skipper, P.L.; Glogowski, J.; Bartsch, H.; Coda, M.; Talaska, G.; Kadlubar, F. Acetylation Phenotype, Carcinogen-Hemoglobin Adducts, and Cigarette Smoking. Cancer Res. 1990, 50, 3002-3004.
113. Talaska, G.T.; Schamer, M.; Skipper, P.; Tannenbaum, S.; Caporaso, N.; Kadlubar, F.F.; Bartsch, H.; Vineis, P. Carcinogen-DNA Adducts in Exfoliated Urothelial Cells: Techniques for Noninvasive Human Biomonitoring. Environ. Health Persp. 1993, 99, 289-291.
114. Kaderlik, K.R.; Kadlubar, F.F. Metabolic Polymorphisms and Carcinogen-DNA Adduct Formation in Human Populations. Pharmacogenetics 1995, 5, s108-s117.
115. Lang, N.P.; Butler, M.A.; Massengill, J.; Lawson, M.; Stotts, R.C.; Hauer-Jensen, M.; Kadlubar, F.F. Rapid Metabolic Phenotypes for Acetyltransferase and Cytochrome P4501A2 and Putative Exposure to Food-Borne Heterocyclic Amines Increase the Risk for Colorectal Cancer or Polyps. Cancer Epidemiol., Biomarkers & Prev. 1994, 3, 675-682.
116. Giovannucci, E.; Rimm, E.B.; Stampfer, M.J.; Colditz, G.A.; Ascherio, A.; Willett, W.C. Intake of Fat, Meat and Fiber in Relation to Risk of Colon Cancer in Men. Cancer Res. 1994, 54, 2390-2397.
117. Sinha, R.; Rothman, N.; Brown, E.D.; Mark, S.D.; Hoover, R.N.; Caporaso, N.E.; Levander, O.A.; Knize, M.G.; Lang, N.P.; Kadlubar, F.F. Pan-Fried Meat Containing High Levels of Heterocyclic Aromatic Amines but Low Levels of Polycyclic Aromatic Hydrocarbons Induces Cytochrome P4501A2 Activity in Humans. Cancer Res. 1994, 54, 6154-6159.
118. Gerhardsson De Verdier, M.; Hagman, U.; Peter, R.K.; Steineck, G.; Överik, E. Meat, Cooking Methods and Colorectal Cancer: A Case-Referent Study in Stockholm. Int. J. Cancer 1991, 49, 520-525.
119. Willett, W.C.; Stampfer, M.J.; Colditz, G.A.; Rosner, B.A.; Speizer, F.E. Relation of Meat, Fat and Fiber Intake to the Risk of Colon Cancer in a Prospective Study Among Women. New Eng. J. Med. 1990, 323, 1664-1672.
120. Shinohara, A.; Saito, K.; Yamazoe, Y.; Kamataki, T.; Kato, R. Acetyl Coenzyme A Dependent Activation of N-Hydroxy Derivatives of Carcinogenic Arylamines: Mechanism of Activation, Species Difference, Tissue Distribution and Acetyl Donor Specificity. Cancer Res. 1986, 46, 4362-4367.
121. Hein. D.W.; Doll, M.A.; Rustan, T.D.; Gray, K.; Feng, Y.; Ferguson, R.J.; Grant, D.M. Metabolic Activation and Deactivation of Arylamine Carcinogens by Recombinant Human NAT1 and Polymorphic NAT2 Acetyltransferases. Carcinogenesis 1993, 14, 1633-1638.
122. Minchin, R.F.; Reeves, P.T.; Teitel, C.H.; McManus, M.E.; Mojarrabi, B.; Ilett, K.F.; Kadlubar, F.F. N- and O-Acetylation of Aromatic and Heterocyclic Amine Carcinogens by Human Monomorphic and Polymorphic Acetyltransferases Expressed in COS-1 Cells. Biochem. Biophys. Res. Comm. 1992, 185, 839-844.
123. Vatsis, K.P.; Weber, W.W. Structural Heterogeneity of Caucasian N-Acetyltransferase at the NAT1 Gene Locus. Arch. Biochem. Biophys. 1993, 301, 71-76.
124. Bell, D.A.; Badawi, A.F.; Lang, N.P.; Ilett, K.F.; Kadlubar, F.F.; Hirvonen, A. Polymorphism in the N-Acetyltransferase 1 (NAT1) Polyadenylation Signal: Association of NAT1 *10 Allele with Higher N-Acetylation Activity in Bladder and Colon Tissue. Cancer Res. 1995, 55, 5226-5229.
125. Bell, D.A.; Stephens, E.A.; Castranio, T.; Umbach, D.M.; Watson, M.; Deakin, M.; Elder, J.; Hendrickse, C.; Duncan, H.; Strange, R.C. Polyadenylation Polymorphism in the Acetyltransferase 1 Gene (NATI) Increases Risk of Colorectal Cancer. Cancer Res. 1995, 55, 3537-3542.
126. Bell, D.A.; Stephens, E.; Castranio, T.; Watson, M.; Deakin, M.; Elder, J.; Duncan, H.; Hendrickse. C.; Strange, R.C. A New Genetic Marker: NAT1 Gene Defect is Associated with Increased Risk for Gastric Cancer. Proc. Am. Assoc. Cancer Res. 1995, 36, 283.
127. Taylor, J.A.; Umbach, D.M.; Stephens, E.; Paulson, D.; Robertson, C.; Mohler, J.L.; Bell, D.A. The Role of N-Acetylation Polymorphisms at NAT1 and NAT2 in Smoking Associated Bladder Cancer. Proc. Am. Assoc. Cancer Res. 1995, 36, 282.
128. Kirlin, W.G.; Trinidad, A.; Yerokun, T.; Ogolla, F.; Ferguson, R.J.; Andrews, A.F.; Brady, P.K.; Hein, D.W. Polymorphic Expression of Acetyl Coenzyme A-Dependent Arylamine N-Acetyltransferase and Acetyl Coenzyme A-Dependent O-Acetyltransferase-Mediated Activation of N-Hydroxyarylamines by Human Bladder Cytosol. Cancer Res. 1989, 49, 2448-2454.
129. Land, S.J.; Zukowski, K.; Lee, M.-S.; Debiec- Rychter, M.; King, C.M.; Yang, C.Y. Metabolism of Aromatic Amines: Relationships of N-Acetylation, O-Acetylation, N,O-Acetyltransfer and Deacetylation in Human Liver and Urinary Bladder. Carcinogenesis 1989, 10, 727-731.
130. Frederickson, S.M.; Messing, E.M.; Reznikoff, C.A.; Swaminathan, S. Relationship Between in Vivo Acetylator Phenotypes and Cytosolic N-Acetyltransferase and O-Acetyltransferase Activities in Human Uroepithelial Cells. Cancer Epidemiol., Biomarkers Prev. 1994, 3, 25-32.
131. Badawi, A.F.; Hirvonen, A.; Bell, D.A.; Lang, N.P.; Kadlubar, F.F. Role of Aromatic Amine Acetyltransferases, NAT1 and NAT2, in Carcinogen-DNA Adduct Formation in the Human Urinary Bladder. Cancer Res. 1995, 55, 5230-5237.
132. Kaderlik, K.R.; Mulder, G.J.; Shaddock, J.G.; Casciano, D.A.; Teitel, C.H.; Kadlubar, F.F. Effect of Glutathione Depletion and Inhibition of Glucuronidation and Sulfation on 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhlP) Metabolism, PhlP-DNA Adduct Formation and Unscheduled DNA Synthesis in Primary Rat Hepatocytes. Carcinogenesis 1994, 15, 1711-1716.
133. Kaderlik, K.R.; Minchin, R.F.; Mulder, G.J.; Ilett, K.F.; Daugaard-Jensen, M.; Teitel, C.H.; Kadlubar, F.F. Metabolic Activation Pathway for the Formation of DNA Adducts of the Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhlP) in Rat Extrahepatic Tissues. Carcinogenesis 1994, 15, 1703-1709.
134. Lin, D.; Meyer, D.J.; Ketterer, B.; Lang, N.P.; Kadlubar, F.F. Effects of Human and Rat Glutathione S-Transferases on the Covalent DNA Binding of the N-Acetoxy Derivatives of Heterocyclic Amine Carcinogenesis in Vitro: A Possible Mechanism of Organ Specificity in Their Carcinogenesis. Cancer Res. 1994, 54, 4920-4926.
135. El-Bayoumy, K. Environmental Carcinogens That May Be Involved in Human Breast Cancer Etiology. Chem. Res. Toxicol. 1992, 5, 585-590.
136. Malejka-Giganti, D.; Rydell, R.E.; Gutmann, H.R. Mammary Carcinogenesis in the Rat by Topical Application of Fluorenylhydroxamic Acids and Their Acetates. Cancer Res. 1977, 37, 111-117.
137. Allaben, W.T.; Weeks, C.E.; Weis, C.C.; Burger, G.T.; King, C.M. Rat Mammary Carcinogenesis after Local Injection of N-Hydroxy-N-acyl-2-aminofluorenes: Relationship to Metabolic Activation. Carcinogenesis 1982, 3, 233-240.
138. Bartsch, H.; Dworkin, C.; Miller, E.C.; Miller, J.A. Formation of Electrophilic N-Acetoxyarylamines in Cytosol from Rat Mammary Gland and Other Tissues by Transacetylation from the Carcinogen N-Hydroxy-4-acetylaminobiphenyl. Biochim. Biophys. Acta 1973; 304, 42-55.
139. Allaben, W.T.; Weis, C.C.; Fullerton, N.F.; Beland, F.A. Formation and Persistence of DNA Adducts from the Carcinogen N-Hydroxy-2-acetylaminofluorene in Rat Mammary Gland in vivo. Carcinogenesis 1983, 4, 1067-1070.
140. King, C.M.; Traub, N.R.; Lortz, Z.M.; Thissen, M.R. Metabolic Activation of Arylhydroxamic Acids by N,O-Acyltransferase of Rat Mammary Gland. Cancer Res. 1979, 39, 3369-3372.
141. Swaminathan, S.; Frederickson, S.M.; Hatcher, J.F. Metabolic Activation of N-Hydroxy-4-acetylaminobiphenyl by Cultured Human Breast Epithelial Cell Line MCF 10A. Carcinogenesis 1994, 15, 611-617.
142. Nagao, M.; Ushijima, T.; Wakabayashi, K.; Ochiai, M.; Kushida, H.; Sugimura, T.; Hasegawa, R.; Shirai, T.; Ito, N. Dietary Carcinogens and Mammary Carcinogenesis. Cancer 1994, 74 (3, Suppl.), 1063-1069.
143. Davis, C.D.; Ghoshal, A.; Schut, H.A.J.; Snyderwine, E.G. Metabolism of the Food-Derived Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by Lactating Fischer 344 Rats and Their Nursing Pups. J. Natl. Cancer Inst. 1994, 86, 1065-1070.
144. Ghoshal, A.; Snyderwine, E.G. Excretion of Food-Derived Heterocyclic Amine Carcinogens into Breast Milk of Lactating Rats and Formation of DNA Adducts in the Newborn. Carcinogenesis 1993, 14, 2199-2203.
145. Hasegawa, R.; Kimura, J.; Yaono, M.; Takahashi, S.; Kato, T.; Futakuchi, M.; Fukutake, M.; Fukutome, K.; Wakabayashi, K.; Sugimura, T.; Ito, N.; Shirai, T. Increased Risk of Mammary Carcinoma Development Following Transplacental and Trans-Breast Milk Exposure to a Food-Derived Carcinogen, 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhlP), in Sprague-Dawley Rats. Cancer Res. 1995, 55, 4333-4338.
146. Davis, C.D.; Ghoshal, A.; Schut, H.A.J.; Snyderwine, E.G. Metabolic Activation of Heterocyclic Amine Food Mutagens in the Mammary Gland of Lactating Fischer 344 Rats. Cancer Lett. 1994, 84, 67-73.
147. Famulok, M.; Bosold, F.; Boche, G. Synthesis of O-Acetyl-N-(4-biphenylyl)hydroxylamine ("N-Acetoxy-4-aminobiphenyl"), an Ultimate Metabolite of Carcinogenic 4-Aminobiophenyl, and Its Reaction with Deoxyguanosine. Angew. Chem. Intl. Ed. Engl. 1989, 28, 337-338.
148. Bosold, F.; Boche, G. The Ultimate Carcinogen, O-Acetyl-N-(2-fluorenyl)hydroxylamine ("N-Acetoxy-2-aminofluorene"), and Its Reaction in vitro to Form 2-(N-(Deoxyguanosin-8-yl)amino]fluorene. Angew. Chem. Intl. Ed. Engl. 1990, 29, 63-64.
149. Famulok, M.; Bosold, F.; Boche, G. Synthesis of N-Acetoxy-2-aminonaphthalene, an Ultimate Carcinogen of the Carcinogenic 2-Naphthylamine, and Its In Vitro Reactions with (Bio)Nucleophiles. Tetrahedron Lett. 1989, 30, 321-324.
150. Hashimoto, Y.; Shudo, K.; Okamoto, T. Modification of DNA with Potent Mutacarcinogenic 2-Amino-6-methyldipyrido[1,2-a:3′,2′-d]imidazole Isolated from a Glutamic Acid Pyrolysate: Structure of the Modified Nucleic Acid Base and Initial Chemical Event Caused by the Mutagen. J. Am. Chem. Soc. 1982, 104, 7636-7640.
151. Smith, B.A.; Guttman, H.R.; Springfield, J.R. Interaction of Nucleophiles with the Enzymatically-Activated Carcinogen, N-Hydroxy-2-acetylaminofluorene, and with the Model Ester, N-Acetoxy-2-aminofluorene. Carcinogenesis 1985, 6, 271-277.
152. N2 at Nitrogen: The Reaction of N-(4-Cyanophenyl)-O-Diphenylphosphinoylhydroxylamine with N-Methylaniline. A Model for the Reaction of Ultimate Carcinogens of Aromatic Amines with (Bio)Nucleophiles. Tetrahedron Lett. 1990, 31, 1689-1692.
153. N1 Solvolysis. J. Am. Chem. Soc. 1991, 113, 3459-3466.
154. Nagaoka, H.; Wakabayashi, K.; Kim, S.-B.; Kim, I.-S.; Tanaka, Y.; Ochiai, M.; Tada, A.; Nukaya, H.; Sugimura, T.; Nagao, M. Adduct Formation at C-8 of Guanine on in vitro Reaction of the Ultimate Form of
155. 2-(2′-deoxyguanosin-8-yl)-PhlP. Carcinogenesis 1992, 13, 629-635.
156. Smith, P.A.S. Aryl and Heteroaryl Azides and Nitrenes. In Azides and Nitrenes: Reactivity and Utility, E.F.V. Scriven, Ed.; Academic Press: San Diego, CA, 1984; pp 95-204.
157. Kadlubar, F.F.; Beland, F.A. Chemical Properties of Ultimate Carcinogenic Metabolites of Arylamines and Arylamides. In Polycyclic Hydrocarbons and Carcinogenesis; R.G. Harvey, Ed.; American Chemical Society: Washington, DC, 1985; pp 341-370.
158. Nakamura, H.; Uetrecht, J.; Cribb, A.E.; Miller, M.A.; Zahid, N.; Hill, J.; Josephy, P.D. Grant, D.M.; Spielberg, S.P. In Vitro Formation, Disposition and Toxicity of N-Acetoxy-sulfamethoxazole, a Potential Mediator of Sulfamethoxazole Toxicity. J. Pharmacol. Exp. Ther. 1995, 274, 1099-1104.
159. Saris, C.P.; van Dijk, W.J.; Westra, J.G.; Hamzink, M.R.J.; van den Werken, G.; Zomer, G.; Stavenuiter, J.F.C. Chemical Properties of the Ultimate Metabolites of 2-Amino-5-phenylpyridine (PHE-P-1) and Its ortho-Methyl Derivative. Chem. Biol. Interact. 1995, 95, 29-40.
160. Marhevka, V.C.; Ebner, N.A.; Sehon, R.D.; Hanna, P.E. Mechanism-Based Inactivation of N-Arylhydroxamic Acid N,O-Acyltransferase by 7-Substituted-N-hydroxy-2-acetamidofluorenes. J. Med. Chem. 1985, 28, 18-24.
161. Elfarra, A.A.; Hanna, P.E. Substituent Effects on the Bioactivation of 2-(N-Hydroxyacetamido)fluorenes by N-Arylhydroxamic Acid N,O-Acyltransferase. J. Med. Chem. 1985, 28, 1453-1460.
162. Boteju, L.W.; Hanna, P.E. Bioactivation of N-Hydroxy-2-acetylaminofluorenes by N,O-Acyltransferase: Substituent Effects on Covalent Binding to DNA. Carcinogenesis 1993, 14, 1651-1657.
163. Boteju, L.W.; Hanna, P.E. Arylamine-Nucleoside Adduct Formation: Evidence for Arylnitrene Involvement in the Reactions of an N-Acetoxyarylamine. Chem. Res. Toxicol. 1994, 7, 684-689.
164. 7 Position. Proc. Natl. Acad. Sci. USA 1992, 89, 8278-8282.